Qsemble Capital Management, LP Bio Rad Laboratories, Inc. Transaction History
Qsemble Capital Management, LP
- $457 Billion
- Q1 2024
A detailed history of Qsemble Capital Management, LP transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Qsemble Capital Management, LP holds 1,639 shares of BIO stock, worth $523,529. This represents 0.12% of its overall portfolio holdings.
Number of Shares
1,639Holding current value
$523,529% of portfolio
0.12%Shares
1 transactions
Others Institutions Holding BIO
# of Institutions
484Shares Held
17.8MCall Options Held
44.9KPut Options Held
79.7K-
Vanguard Group Inc Valley Forge, PA2.42MShares$773 Million0.02% of portfolio
-
Black Rock Inc. New York, NY1.48MShares$473 Million0.01% of portfolio
-
Veritas Asset Management LLP1.15MShares$366 Million3.33% of portfolio
-
State Street Corp Boston, MA874KShares$279 Million0.01% of portfolio
-
Earnest Partners LLC Atlanta, GA515KShares$164 Million0.84% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $7.87B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...